<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32482366</PMID><DateCompleted><Year>2020</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-9133</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi</Title><ISOAbbreviation>J Microbiol Immunol Infect</ISOAbbreviation></Journal><ArticleTitle>Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?</ArticleTitle><Pagination><StartPage>505</StartPage><EndPage>512</EndPage><MedlinePgn>505-512</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jmii.2020.05.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1684-1182(20)30127-4</ELocationID><Abstract><AbstractText>Co-infection has been reported in patients with severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome, but there is limited knowledge on co-infection among patients with coronavirus disease 2019 (COVID-19). The prevalence of co-infection was variable among COVID-19 patients in different studies, however, it could be up to 50% among non-survivors. Co-pathogens included bacteria, such as Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae, Mycoplasma pneumoniae, Chlamydia pneumonia, Legionella pneumophila and Acinetobacter baumannii; Candida species and Aspergillus flavus; and viruses such as influenza, coronavirus, rhinovirus/enterovirus, parainfluenza, metapneumovirus, influenza B virus, and human immunodeficiency virus. Influenza A was one of the most common co-infective viruses, which may have caused initial false-negative results of real-time reverse-transcriptase polymerase chain reaction for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Laboratory and imaging findings alone cannot help distinguish co-infection from SARS-CoV-2 infection. Newly developed syndromic multiplex panels that incorporate SARS-CoV-2 may facilitate the early detection of co-infection among COVID-19 patients. By contrast, clinicians cannot rule out SARS-CoV-2 infection by ruling in other respiratory pathogens through old syndromic multiplex panels at this stage of the COVID-19 pandemic. Therefore, clinicians must have a high index of suspicion for coinfection among COVID-19 patients. Clinicians can neither rule out other co-infections caused by respiratory pathogens by diagnosing SARS-CoV-2 infection nor rule out COVID-19 by detection of non-SARS-CoV-2 respiratory pathogens. After recognizing the possible pathogens causing co-infection among COVID-19 patients, appropriate antimicrobial agents can be recommended.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Chih-Cheng</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Cheng-Yi</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsueh</LastName><ForeName>Po-Ren</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Departments of Laboratory Medicine and Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: hsporen@ntu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Microbiol Immunol Infect</MedlineTA><NlmUniqueID>100956211</NlmUniqueID><ISSNLinking>1684-1182</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000890">Anti-Infective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000706170">Covid-19 aAPC vaccine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011933">Reagent Kits, Diagnostic</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000890" MajorTopicYN="N">Anti-Infective Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019411" MajorTopicYN="N">Clinical Laboratory Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011933" MajorTopicYN="N">Reagent Kits, Diagnostic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Co-infection</Keyword><Keyword MajorTopicYN="N">Influenza viruses</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>5</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32482366</ArticleId><ArticleId IdType="pmc">PMC7245213</ArticleId><ArticleId IdType="doi">10.1016/j.jmii.2020.05.013</ArticleId><ArticleId IdType="pii">S1684-1182(20)30127-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019</Citation></Reference><Reference><Citation>Lai C.C., Shih T.P., Ko W.C., Tang H.J., Hsueh P.R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020;55:105924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7127800</ArticleId><ArticleId IdType="pubmed">32081636</ArticleId></ArticleIdList></Reference><Reference><Citation>Colson P., Rolain J.M., Lagier J.C., Brouqui P., Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents. 2020;55:105932.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135139</ArticleId><ArticleId IdType="pubmed">32145363</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko W.C., Rolain J.M., Lee N.Y., Chen P.L., Huang C.T., Lee P.I. Arguments in favor of remdesivir for treating SARS-CoV-2 infections. Int J Antimicrob Agents. 2020;55:105933.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135364</ArticleId><ArticleId IdType="pubmed">32147516</ArticleId></ArticleIdList></Reference><Reference><Citation>Metlay J.P., Waterer G.W., Long A.C., Anzueto A., Brozek J., Crothers K. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200:e45&#x2013;e67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6812437</ArticleId><ArticleId IdType="pubmed">31573350</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahariadis G., Gooley T.A., Ryall P., Hutchinson C., Latchford M.I., Fearon M.A. Risk of ruling out severe acute respiratory syndrome by ruling in another diagnosis: variable incidence of atypical bacteria coinfection based on diagnostic assays. Canc Res J. 2006;13:17&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2539008</ArticleId><ArticleId IdType="pubmed">16470249</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee N., Chan P.K., Yu I.T., Tsoi K.K., Lui G., Sung J.J. Co-circulation of human metapneumovirus and SARS-associated coronavirus during a major nosocomial SARS outbreak in Hong Kong. J Clin Virol. 2007;40:333&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108220</ArticleId><ArticleId IdType="pubmed">17936066</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfaraj S.H., Al-Tawfiq J.A., Altuwaijri T.A., Memish Z.A. Middle East Respiratory Syndrome Coronavirus and pulmonary tuberculosis coinfection: implications for infection control. Intervirology. 2017;60:53&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179530</ArticleId><ArticleId IdType="pubmed">28683463</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfaraj S.H., Al-Tawfiq J.A., Alzahrani N.A., Altwaijri T.A., Memish Z.A. The impact of co-infection of influenza A virus on the severity of Middle East Respiratory Syndrome Coronavirus. J Infect. 2017;74:521&#x2013;523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7126798</ArticleId><ArticleId IdType="pubmed">28189714</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi Y.M., Al-Omari A., Mandourah Y., Al-Hameed F., Sindi A.A., Alraddadi B. Critically ill patients with the Middle East Respiratory Syndrome: a multicenter retrospective cohort study. Crit Care Med. 2017;45:1683&#x2013;1695.</Citation><ArticleIdList><ArticleId IdType="pubmed">28787295</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Arentz M., Yim E., Klaff L., Lokhandwala S., Riedo F.X., Chong M. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. J Am Med Assoc. 2020 Mar 19 doi: 10.1001/jama.2020.4326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.4326</ArticleId><ArticleId IdType="pmc">PMC7082763</ArticleId><ArticleId IdType="pubmed">32191259</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Liu H.G., Liu W., Liu J., Liu K., Shang J. [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia] Zhonghua Jiehe He Huxi Zazhi. 2020;43:203&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">32164089</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M., Wu Q., Xu W., Qiao B., Wang J., Zheng H. Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan. medRxiv. 2020 Feb 12 [Online ahead of print]</Citation></Reference><Reference><Citation>Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020 Mar 13 doi: 10.1001/jamainternmed.2020.0994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Young B.E., Ong S.W.X., Kalimuddin S., Low J.G., Tan S.Y., Loh J. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. J Am Med Assoc. 2020 Mar 3 doi: 10.1001/jama.2020.3204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.3204</ArticleId><ArticleId IdType="pmc">PMC7054855</ArticleId><ArticleId IdType="pubmed">32125362</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Q., Lu P., Fan Y., Xia Y., Liu M. The clinical characteristics of pneumonia patients co-infected with 2019 novel coronavirus and influenza virus in Wuhan, China. J Med Virol. 2020 Mar 20 doi: 10.1002/jmv.25781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25781</ArticleId><ArticleId IdType="pmc">PMC7228290</ArticleId><ArticleId IdType="pubmed">32196707</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Quinn J., Pinsky B., Shah N.H., Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. J Am Med Assoc. 2020 Apr 15 doi: 10.1001/jama.2020.6266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6266</ArticleId><ArticleId IdType="pmc">PMC7160748</ArticleId><ArticleId IdType="pubmed">32293646</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing Q., Li G., Xing Y., Chen T., Li W., Ni W. Precautions are needed for COVID-19 patients with coinfection of common respiratory pathogens. medRxiv. 2020 Mar 5 doi: 10.1101/2020.02.29.2002769. [Online ahead of print]</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.02.29.2002769</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Chen K., Liu M., Xu H., Xu Q. The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia. J Infect. 2020 Apr 2 doi: 10.1016/j.jinf.2020.04.001. [Online ahead of print]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.04.001</ArticleId><ArticleId IdType="pmc">PMC7169899</ArticleId><ArticleId IdType="pubmed">32325129</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W., Northwell COVID-19 research consortium Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. J Am Med Assoc. 2020 doi: 10.1001/jama.2020.6775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangrillo A., Beretta L., Scandroglio A.M., Monti G., Fominskiy E., Colombo S. For the COVID-BioB Study Group. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc. 2020 Apr 23 [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10692521</ArticleId><ArticleId IdType="pubmed">32900326</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F., Cao Y., Xu S., Zhou M. Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China. J Med Virol. 2020 Mar 11 doi: 10.1002/jmv.25732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25732</ArticleId><ArticleId IdType="pmc">PMC7228399</ArticleId><ArticleId IdType="pubmed">32160316</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan B.E., Lim K.G.E., Chong V.C.L., Chan S.S.W., Ong K.H., Kuperan P. COVID-19 and Mycoplasma pneumoniae coinfection. Am J Hematol. 2020 Mar 15 doi: 10.1002/ajh.25785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25785</ArticleId><ArticleId IdType="pmc">PMC7227380</ArticleId><ArticleId IdType="pubmed">32173883</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Cai Y., Huang X., Yu X., Zhao L., Wang F. Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China. Emerg Infect Dis. 2020 Mar 11 doi: 10.3201/eid2606.200299.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2606.200299</ArticleId><ArticleId IdType="pmc">PMC7258479</ArticleId><ArticleId IdType="pubmed">32160148</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D., Wang D., Dong J., Wang N., Huang H., Xu H. False-negative results of real-time reverse-transcriptase polymerase chain reaction for severe acute respiratory syndrome coronavirus 2: role of deep-learning-based CT diagnosis and insights from two cases. Korean J Radiol. 2020;21:505&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7082661</ArticleId><ArticleId IdType="pubmed">32174053</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodamoradi Z., Moghadami M., Lotfi M. Co-infection of coronavirus disease 2019 and influenza A: a report from Iran. Arch Iran Med. 2020;23:239&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">32271596</ArticleId></ArticleIdList></Reference><Reference><Citation>Arashiro T., Nakamura S., Asami T., Mikuni H., Fujiwara E., Sakamoto S. SARS-CoV-2 and Legionella co-infection in a person returning from a Nile Cruise. J Trav Med. 2020 Apr 16 doi: 10.1093/jtm/taaa053. pii: taaa053. [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taaa053</ArticleId><ArticleId IdType="pmc">PMC7184515</ArticleId><ArticleId IdType="pubmed">32297939</ArticleId></ArticleIdList></Reference><Reference><Citation>Duployez C., Guern R.L., Tinez C., Lejeune A.L., Robriquet L., Six S. Panton-Valentine leukocidin-secreting Staphylococcus aureus pneumonia complicating COVID-19. Emerg Infect Dis. 2020;26(8) doi: 10.3201/eid2608.201413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2608.201413</ArticleId><ArticleId IdType="pmc">PMC7392470</ArticleId><ArticleId IdType="pubmed">32298228</ArticleId></ArticleIdList></Reference><Reference><Citation>Liew J.R.P., Lim Y.R.D., Liew J.Y.C., Poh C.C.A. Clinics in diagnostic imaging: COVID-19 atypical pneumonia. Singap Med J. 2020 Apr 3 doi: 10.11622/smedj.2020045.</Citation><ArticleIdList><ArticleId IdType="doi">10.11622/smedj.2020045</ArticleId><ArticleId IdType="pmc">PMC7926606</ArticleId><ArticleId IdType="pubmed">32241067</ArticleId></ArticleIdList></Reference><Reference><Citation>Lescure F.X., Bouadma L., Nguyen D., Parisey M., Wicky P.H., Behillil S. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 Mar 27 doi: 10.1016/S1473-3099(20)30200-0. pii: S1473-3099(20)30200-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30200-0</ArticleId><ArticleId IdType="pmc">PMC7156120</ArticleId><ArticleId IdType="pubmed">32224310</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu W.L., Liu W.L., Chan K.S., Yang C.C., Tan C.K., Tsai C.L. High-level ambient particulate matter before influenza attack with increased incidence of Aspergillus antigenemia in southern Taiwan, 2016. J Microbiol Immunol Infect. 2018;51:141&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">28065414</ArticleId></ArticleIdList></Reference><Reference><Citation>Su I.C., Lee K.L., Liu H.Y., Chuang H.C., Chen L.Y., Lee Y.J. Severe community-acquired pneumonia due to Pseudomonas aeruginosa coinfection in an influenza A(H1N1)pdm09 patient. J Microbiol Immunol Infect. 2019;52:365&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pubmed">29958866</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung H.M., Yang S.L., Chen C.J., Chiu C.H., Kuo C.Y., Huang K.A. Molecular epidemiology and clinical features of rhinovirus infections among hospitalized patients in a medical center in Taiwan. J Microbiol Immunol Infect. 2019;52:233&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">30201131</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.H., Su M.C., Tien N., Huang C.J., Lan Y.C., Lin C.S. Epidemiology of human coronavirus NL63 infection among hospitalized patients with pneumonia in Taiwan. J Microbiol Immunol Infect. 2017;50:763&#x2013;770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7105056</ArticleId><ArticleId IdType="pubmed">26746130</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramanan P., Bryson A.L., Binnicker M.J., Pritt B.S., Patel R. Syndromic panel-based testing in clinical microbiology. Clin Microbiol Rev. 2017;31(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5740973</ArticleId><ArticleId IdType="pubmed">29142077</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.H., Ruan S.Y., Pan S.C., Lee T.F., Chien J.Y., Hsueh P.R. Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units. J Microbiol Immunol Infect. 2019;52:920&#x2013;928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185395</ArticleId><ArticleId IdType="pubmed">31806539</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. J Am Med Assoc. 2020 Feb 7 doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Feb 28 doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/critical-care/Accessed 8 May 2020.</Citation></Reference><Reference><Citation>Bjimra A., Morgan R.L., Shumaker A.H., Lavergne V., Baden L., Cheng V.C.C. Infectious diseases society of America guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis. 2020 Apr 27 doi: 10.1093/cid/ciaa478. ciaa478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa478</ArticleId><ArticleId IdType="pmc">PMC7197612</ArticleId><ArticleId IdType="pubmed">32338708</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhazzani W., M&#xf8;ller M.H., Arabi Y.M., Loeb M., Gong M.N., Fan E. Surviving sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19) Crit Care Med. 2020 Mar 27 doi: 10.1097/CCM.0000000000004363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004363</ArticleId><ArticleId IdType="pmc">PMC7176264</ArticleId><ArticleId IdType="pubmed">32224769</ArticleId></ArticleIdList></Reference><Reference><Citation>Uyeki T.M., Bernstein H.H., Bradley J.S., Englund J.A., File T.M., Fry A.M. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2019;68:895&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6769232</ArticleId><ArticleId IdType="pubmed">30834445</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/clinical-management-covid-19.html#8. Accessed 8 May 2020.</Citation></Reference><Reference><Citation>Chou C.C., Shen C.F., Chen S.J., Chen H.M., Wang Y.C., Chang W.S. Infectious diseases society of Taiwan,; Taiwan society of pulmonary and critical care medicine; medical foundation in memory of Dr. Deh-Lin Cheng; foundation of professor Wei-Chuan Hsieh for infectious diseases research and education; CY Lee's research foundation for pediatric infectious diseases and vaccines,; 4th guidelines recommendations for evidence-based antimicrobial agents use in Taiwan (GREAT) working group. Recommendations and guidelines for the treatment of pneumonia in Taiwan. J Microbiol Immunol Infect. 2019;52:172&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">30612923</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.nice.org.uk/guidance/ng165/chapter/4-Managing-suspected-or-confirmed-pneumonia#antibiotic-treatment. Accessed 8 May 2020.</Citation></Reference><Reference><Citation>Jin Y.H., Cai L., Cheng Z.S., Cheng H., Deng T., Fan Y.P. For the Zhongnan hospital of Wuhan university novel coronavirus management and research Team, evidence-based medicine Chapter of China international exchange and promotive association for medical and Health care (CPAM). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) Mil Med Res. 2020;7:4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7003341</ArticleId><ArticleId IdType="pubmed">32029004</ArticleId></ArticleIdList></Reference><Reference><Citation>Huttner B., Catho G., Pano-Pardo J.R., Pulcini C., Schouten J. COVID-19: don't neglect antimicrobial stewardship principles! Clin Micrbiol Infect. 2020 Apr 29 doi: 10.1016/j.cmi.2020.04.024. pii: S1198-743X(20)30232-30239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.04.024</ArticleId><ArticleId IdType="pmc">PMC7190532</ArticleId><ArticleId IdType="pubmed">32360446</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>